Desloratadine

Desloratadine

SCHEMBL4425

Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

HRH1

The experimentally established mechanism targets of Desloratadine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 known ✓ P35367 14/20 1.00
MEN1 O00255 1/20 1.00
LMNA P02545 1/20 1.00
ADRB2 P07550 1/20 1.00
CHRM2 P08172 1/20 1.00
CHRM4 P08173 1/20 1.00
ABCB1 P08183 1/20 1.00
HTR1A P08908 1/20 1.00
CHRM5 P08912 1/20 1.00
ADRA2A P08913 1/20 1.00
CHRM1 P11229 1/20 1.00
DRD2 P14416 1/20 1.00
ADRA2B P18089 1/20 1.00
ADRA2C P18825 1/20 1.00
CHRM3 P20309 1/20 1.00
DRD1 P21728 1/20 1.00
TBXA2R P21731 1/20 1.00
DRD4 P21917 1/20 1.00
PTGS1 P23219 1/20 1.00
SLC6A2 P23975 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Desloratadine SCHEMBL29371361 1.00 HRH1 (1.00) HRH1MEN1LMNAADRB2CHRM2
Desloratadine SCHEMBL29390260 1.00 HRH1 (1.00) HRH1MEN1LMNAADRB2CHRM2
Desloratadine SCHEMBL5200429 0.99 HRH1 (0.97) HRH1MEN1LMNAADRB2CHRM2
Desloratadine SCHEMBL5200118 0.99 HRH1 (0.97) HRH1MEN1LMNAADRB2CHRM2
Desloratadine SCHEMBL4574215 0.99 HRH1 (0.97) HRH1MEN1LMNAADRB2CHRM2
Desloratadine SCHEMBL5198706 0.99 HRH1 (0.97) HRH1MEN1LMNAADRB2CHRM2
Desloratadine SCHEMBL5374223 0.97 HRH1 (0.95) HRH1MEN1LMNAADRB2CHRM2
Desloratadine SCHEMBL5378852 0.97 HRH1 (0.95) HRH1MEN1LMNAADRB2CHRM2
Desloratadine SCHEMBL3558046 0.94 HRH1 (0.89) HRH1MEN1LMNAADRB2CHRM2
Desloratadine SCHEMBL28307951 0.94 HRH1 (0.89) HRH1MEN1LMNAADRB2CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 22707 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122036817-A C-alkyl carbon glycoside and preparation method thereof 江西师范大学 2026-05-15 CN claimed
WO-2026100654-A1 NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD 株式会社インファーマシア 2026-05-15 WO claimed
EP-4740962-A1 PHARMACEUTICAL COMPOSITION, FORMULATION CONTAINING PHARMACEUTICAL COMPOSITION, KIT CONTAINING PHARMACEUTICAL COMPOSITION, PREPARATION METHOD FOR PHARMACEUTICAL COMPOSITION, AND USE OF PHARMACEUTICAL COMPOSITION Shanghai WD Pharmaceutical Co., Ltd (CN) 2026-05-13 EP claimed
EP-4736841-A1 A MUCOADHESIVE LAYER FOR BUCCAL ADMINISTRATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT IQ medical GmbH (DE) 2026-05-06 EP claimed
EP-4731194-A1 MATERIALS AND METHODS FOR MITIGATING THE PRESENCE OF NITROSAMINES IN PACKAGING USING AN ACTIVE AGENT CSP Technologies, Inc. (US) 2026-04-29 EP claimed
EP-4704971-A1 GAMMA STIMULATION AND NEUROMODULATOR COMBINATION THERAPY Cognito Therapeutics, Inc. (US) 2026-03-11 EP claimed
WO-2026042047-A1 COMPOSITIONS AND ARTICLES COMPRISING REVERSIBLE COMPLEXES OF CROSSLINKED CARRAGEENAN JOHNSON & JOHNSON VISION CARE, INC. (US) 2026-02-26 WO claimed
EP-4699655-A2 COMPOUNDS TMEM16A LIMITED (GB) 2026-02-25 EP claimed
US-12550885-B2 Red blood cell storage solutions, solution additives, and methods for improving the storage of red blood cells UNIVERSITY OF CINCINNATI (US) 2026-02-17 US claimed
EP-4691568-A2 LOW-DOSE BRIMONIDINE COMBINATIONS AND USES THEREOF Eye Therapies, LLC (US) 2026-02-11 EP claimed
WO-1999024421-A1 IMIDAZOYLALKYL SUBSTITUTED WITH A FIVE, SIX OR SEVEN MEMBERED HETEROCYCLIC RING CONTAINING ONE NITROGEN ATOM SCHERING CORPORATION (US) 1999-05-20 WO claimed
WO-1999024405-A1 H3 RECEPTOR LIGANDS OF THE PHENYL-ALKYL-IMIDAZOLES TYPE SCHERING CORPORATION (US) 1999-05-20 WO claimed
WO-1999024406-A1 PHENYL-ALKYL-IMIDAZOLES AS H3 RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 1999-05-20 WO claimed
US-5869479-A ADMINISTERING HISTAMINE H1 RECEPTOR ANTAGONISTS AND HISTAMINE H3 RECEPTOR ANTAGONISTS; NASAL DECONGESTANT WITHOUT THE NERVOUS SYSTEM OR CARDIOVASCULAR SIDE EFFECTS SCHERING CORPORATION (US) 1999-02-09 US claimed
WO-1998034614-A1 LACTOSE-FREE, NON-HYGROSCOPIC AND ANHYDROUS PHARMACEUTICAL COMPOSITIONS OF DESCARBOETHOXYLORATADINE SEPRACOR, INC. (US) 1998-08-13 WO claimed
WO-1998006394-A1 TREATMENT OF UPPER AIRWAY ALLERGIC RESPONSES WITH A COMBINATION OF HISTAMINE RECEPTOR ANTAGONISTS SCHERING CORPORATION (US) 1998-02-19 WO claimed
US-5595997-A FEWER SIDE EFFECTS THAN WITH OTHER NON-SEDATING ANTIHISTAMINES SEPRACOR INC. (US) 1997-01-21 US claimed
EP-0396404-B1 Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine SCHERING CORP (US) 1994-02-16 EP claimed
EP-0152897-B1 8-Chloro-6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6]cyclohepta-[1,2-b]pyridine and its salts, processes for the production thereof and pharmaceutical compositions containing these compounds SCHERING CORPORATION (US) 1989-10-11 EP claimed
US-4141791-A Milk coagulating microbial enzyme MARTINI ALESSANDRO 1979-02-27 US claimed